Genelux Corporation (GNLX)

Genelux Statistics

Total Valuation

Genelux has a market cap or net worth of $107.41 million. The enterprise value is $82.11 million.

Market Cap	107.41M
Enterprise Value	82.11M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Genelux has 37.29 million shares outstanding. The number of shares has increased by 28.74% in one year.

Current Share Class	37.29M
Shares Outstanding	37.29M
Shares Change (YoY)	+28.74%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	11.08%
Owned by Institutions (%)	13.19%
Float	30.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13,892.32
Forward PS	n/a
PB Ratio	4.06
P/TBV Ratio	4.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10,263.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.07.

Current Ratio	4.57
Quick Ratio	4.48
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -130.58% and return on invested capital (ROIC) is -79.03%.

Return on Equity (ROE)	-130.58%
Return on Assets (ROA)	-63.28%
Return on Invested Capital (ROIC)	-79.03%
Return on Capital Employed (ROCE)	-113.96%
Revenue Per Employee	$333
Profits Per Employee	-$1.24M
Employee Count	24
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.52% in the last 52 weeks. The beta is -0.39, so Genelux's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-16.52%
50-Day Moving Average	3.49
200-Day Moving Average	2.85
Relative Strength Index (RSI)	49.28
Average Volume (20 Days)	200,166

Short Selling Information

The latest short interest is 2.56 million, so 6.87% of the outstanding shares have been sold short.

Short Interest	2.56M
Short Previous Month	2.35M
Short % of Shares Out	6.87%
Short % of Float	8.36%
Short Ratio (days to cover)	14.48

Income Statement

In the last 12 months, Genelux had revenue of $8,000 and -$29.87 million in losses. Loss per share was -$0.95.

Revenue	8,000
Gross Profit	8,000
Operating Income	-31.70M
Pretax Income	-25.78M
Net Income	-29.87M
EBITDA	-31.46M
EBIT	-31.70M
Loss Per Share	-$0.95

Balance Sheet

The company has $30.90 million in cash and $1.87 million in debt, giving a net cash position of $29.03 million or $0.78 per share.

Cash & Cash Equivalents	30.90M
Total Debt	1.87M
Net Cash	29.03M
Net Cash Per Share	$0.78
Equity (Book Value)	26.27M
Book Value Per Share	0.77
Working Capital	24.65M

Cash Flow

In the last 12 months, operating cash flow was -$21.23 million and capital expenditures -$381,000, giving a free cash flow of -$21.61 million.

Operating Cash Flow	-21.23M
Capital Expenditures	-381,000
Free Cash Flow	-21.61M
FCF Per Share	-$0.58

Margins

Gross Margin	100.00%
Operating Margin	-396,200.00%
Pretax Margin	-373,362.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genelux does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-28.74%
Shareholder Yield	-28.74%
Earnings Yield	-26.88%
FCF Yield	-19.44%

Analyst Forecast

The average price target for Genelux is $18.25, which is 533.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.25
Price Target Difference	533.68%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	650.53%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genelux has an Altman Z-Score of -3.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.41
Piotroski F-Score	2